International Federation of Red Cross and Red Crescent Societies & Gilead Sciences

International Federation of Red Cross and Red Crescent Societies: The International Federation of Red Cross and Red Crescent Societies is involved in the response to the Ebola outbreak in the Democratic Republic of the Congo, emphasizing the need for quick action and community engagement.

Gilead Sciences: Gilead Sciences' antiviral drug remdesivir and experimental drug obeldesivir are being prioritized for clinical trials to treat or prevent the Bundibugyo ebolavirus, indicating its significant role in potential therapies.

International Federation of Red Cross and Red Crescent Societies: The International Federation of Red Cross and Red Crescent Societies is actively involved in the Ebola response, highlighting the challenges posed by insecurity and displacement.

Gilead Sciences: Gilead Sciences is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.

International Federation of Red Cross and Red Crescent Societies: The International Federation of Red Cross and Red Crescent Societies>>> has highlighted the challenges of the Ebola outbreak, including the rapid spread and the deaths of its volunteers, emphasizing the need for increased contact tracing and resources.

Gilead Sciences: Gilead Sciences' experimental oral COVID antiviral drug, Obeldesivir, is being considered for use as a preventative treatment for Ebola contacts, under strict protocol.